These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5826769)

  • 1. Cholesterol lowering measures with clinical observations on a thyroid analogue (Sodium Dextrothyroxine) NaDT4; 91 cases--4 year study.
    Cooper EE; Michel AM
    Med Times; 1965 Oct; 93(10):1089-94. PubMed ID: 5826769
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of hypocholesterolemic agents on cholesterol esterification in vitro.
    Schweppe JS; Jungmann RA
    Proc Soc Exp Biol Med; 1971 Feb; 136(2):449-51. PubMed ID: 5544478
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypolipidemic agents--newly approved.
    Duncan GG
    Metabolism; 1967 Sep; 16(9):775-6. PubMed ID: 4860365
    [No Abstract]   [Full Text] [Related]  

  • 4. Dextrothyroxine for lowering serum cholesterol. Analysis of data on 6066 patients.
    Bechtol LD; Warner WL
    Angiology; 1969 Nov; 20(10):565-79. PubMed ID: 5347944
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of dextrothyroxine on serum lipoprotein and cholesterol levels.
    Searcy RL; Hungerford DA; Low EM
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):177-86. PubMed ID: 4967872
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of triparanol and sodium dextrothyroxine to lower serum cholesterol.
    GOYETTE EM; SAAD A
    Angiology; 1962 Feb; 13():88-93. PubMed ID: 13900898
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on sodium D-thyroxine as a hypocholesteremic agent in persons with hypercholesteremia with and without ischemic heart disease.
    WINTERS WL; SOLOFF LA
    Am J Med Sci; 1962 Apr; 243():458-69. PubMed ID: 14007620
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of sodium dextrothyroxine in patients receiving anticoagulants.
    OWENS JC; NEELY WB; OWEN WR
    N Engl J Med; 1962 Jan; 266():76-9. PubMed ID: 14482918
    [No Abstract]   [Full Text] [Related]  

  • 10. New molecular targets for cholesterol-lowering therapy.
    Izzat NN; Deshazer ME; Loose-Mitchell DS
    J Pharmacol Exp Ther; 2000 May; 293(2):315-20. PubMed ID: 10772997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium dextrothyroxine as a hypocholesterolemic agent: retrospective analysis of 6000 patients.
    Williams W; Warner W
    Manit Med Rev; 1968 Oct; 48(8):374-6. PubMed ID: 5724155
    [No Abstract]   [Full Text] [Related]  

  • 12. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of cholesterol-lowering medications and age-related macular degeneration.
    McGwin G; Xie A; Owsley C
    Ophthalmology; 2005 Mar; 112(3):488-94. PubMed ID: 15745779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a hypocholesterolemic agent. Dextrothyroxine sodium (Choloxin).
    JAMA; 1969 May; 208(6):1014-5. PubMed ID: 5818672
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience with dextrothyroxine in hypercholesterolemia.
    Owen WR
    Manit Med Rev; 1968 Oct; 48(8):370-3. PubMed ID: 5724154
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects.
    Morkin E; Ladenson P; Goldman S; Adamson C
    J Mol Cell Cardiol; 2004 Dec; 37(6):1137-46. PubMed ID: 15572044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of iodinated, hypocholesteremic preparations, and ACTH on incorporation of labeled cholesterol into the adrenal glands].
    Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV
    Fiziol Zh (1978); 1981; 27(1):64-71. PubMed ID: 6257561
    [No Abstract]   [Full Text] [Related]  

  • 18. Statins and cognitive function in the elderly: the Cardiovascular Health Study.
    Bernick C; Katz R; Smith NL; Rapp S; Bhadelia R; Carlson M; Kuller L;
    Neurology; 2005 Nov; 65(9):1388-94. PubMed ID: 16275825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol-lowering margarines.
    Med Lett Drugs Ther; 1999 Jun; 41(1055):56-8. PubMed ID: 10436768
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects.
    Nguyen TD; Kang JH; Lee MS
    Int J Food Microbiol; 2007 Feb; 113(3):358-61. PubMed ID: 17140690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.